John W. Martin
Corporate Officer/Principal at The European Commission
John W. Martin active positions
Companies | Position | Start | End |
---|---|---|---|
The European Commission | Corporate Officer/Principal | 2010-11-24 | - |
University College London | Corporate Officer/Principal | - | - |
Career history of John W. Martin
Former positions of John W. Martin
Companies | Position | Start | End |
---|---|---|---|
United Kingdom Ministry of Home Affairs | Corporate Officer/Principal | 2005-12-31 | 2005-12-31 |
The European Society of Cardiology | Corporate Officer/Principal | 2001-12-31 | 2001-12-31 |
Wellcome Research Laboratories | Chief Tech/Sci/R&D Officer | 1995-12-31 | 1995-12-31 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2009-09-10 | - |
Founder | 2009-09-10 | - |
Statistics
International
United Kingdom | 4 |
United States | 2 |
France | 2 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sectoral
Government | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Wellcome Research Laboratories | |
The European Society of Cardiology | |
United Kingdom Ministry of Home Affairs | Government |
The European Commission | Government |
- Stock Market
- Insiders
- John W. Martin
- Experience